2026-01-12 - Analysis Report
**English Report**
================

**Company Overview**
-------------------
Prologis Inc (PLD) is a real estate investment company specializing in logistics and industrial properties.

**Return Rate Comparison**
-------------------------
| Ticker | Cumulative Return |
| --- | --- |
| PLD | 65.93% |
| VOO (S&P 500) | 94.03% |
| Divergence | -28.10% |

PLD's cumulative return is lower than the S&P 500 (VOO), indicating a divergence of -28.10%.

**CAGR, MDD, Alpha, Beta Analysis**
-----------------------------------
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 4.0% | 17.8% | 0.0% | 0.8 | 54.5B |
| 2017-2019 | 37.0% | 17.8% | 20.0% | 0.7 | 82.8B |
| 2018-2020 | 11.0% | 17.8% | -9.0% | 1.0 | 92.6B |
| 2019-2021 | 89.0% | 14.4% | 46.0% | 1.0 | 156.4B |
| 2020-2022 | 2.0% | 32.1% | 4.0% | 1.1 | 104.7B |
| 2021-2023 | 19.0% | 32.1% | 18.0% | 1.0 | 123.8B |
| 2022-2024 | -61.0% | 32.1% | -80.0% | 1.0 | 98.2B |
| 2023-2025 | 2.0% | 24.0% | -60.0% | 1.0 | 118.6B |

**Recent Stock Price Fluctuation**
--------------------------------
| SMA (Days) | Value |
| --- | --- |
| 5-Day | $128.37 |
| 20-Day | $128.56 |
| 60-Day | $126.60 |

**Moving Average Analysis**
---------------------------

The 5-day SMA is lower than the 20-day SMA, indicating a short-term downtrend. The 60-day SMA is significantly lower, suggesting a longer-term downtrend.

**Technical Indicators Analysis**
--------------------------------

| Index | Value |
| --- | --- |
| RSI | 57.12 |
| PPO | -0.11 |
| MRI | 0.70 |
| Expected Return | 13.70% |

The RSI is above 30, indicating overbought conditions. The PPO is negative, indicating a downtrend. The MRI is 0.70, indicating a Medium risk level.

**News and Significant Events**
-----------------------------
| Date | Headline |
| --- | --- |
| 2026-01-11 | Prologis, Inc. $PLD Shares Acquired by New York State Teachers Retirement System - MarketBeat |
| 2026-01-10 | Is Prologis (PLD) Starting To Look Expensive After Strong Multi-year Share Price Gains? - Yahoo Finance |
| 2026-01-07 | This 100-year-old stock-market indicator just flashed a buy signal. Hereâ€™s how investors should read it. - MarketWatch |
| 2026-01-10 | Doug Kass: What a 50-Year-Old Stock Chart Can Teach Today's Bulls - TheStreet Pro |
| 2026-01-09 | UBS Raises Price Target for Prologis (PLD) Amidst Consistent Buy Ratings | PLD Stock News - GuruFocus |
| 2026-01-05 | Insider Sale: Director at $PLD Sells 80,000 Shares - Quiver Quantitative |

**Analyst Opinions**
-------------------
**Analyst Consensus**

* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.92 (~Buy)
* Opinions: 20
* Target Price (avg/high/low): 133.40 / 155.00 / 118.00

**Earnings Analysis**
--------------------
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-28 | $0.82 | $2.21B |
| 2025-07-30 | $0.61 | $2.18B |
| 2025-04-29 | $0.64 | $2.14B |
| 2025-02-14 | $1.38 | $2.20B |
| 2024-10-25 | $1.08 | $2.04B |

The company's EPS and revenue have been relatively stable in the past few quarters, with a slight increase in revenue.

**Financial Information**
------------------------
**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $2.21B | 74.98% |
| 2025-06-30 | $2.18B | 74.68% |
| 2025-03-31 | $2.14B | 74.34% |
| 2024-12-31 | $2.20B | 76.39% |
| 2024-09-30 | $2.04B | 76.00% |

**Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $52.64B | 1.45% |
| 2025-06-30 | $52.73B | 1.08% |
| 2025-03-31 | $53.47B | 1.11% |
| 2024-12-31 | $53.95B | 2.37% |
| 2024-09-30 | $53.07B | 1.90% |

The company's revenue and profit margin have been relatively stable in the past few quarters, with a slight increase in revenue. The ROE has been decreasing in the past two quarters.

**Comprehensive Analysis**
------------------------

Based on the analysis, PLD's stock price has been in a downtrend in the short-term, but has relatively stable earnings and revenue in the past few quarters. The company's ROE has been decreasing in the past two quarters. The analyst consensus is Buy, but the stock price may be overbought according to the RSI. A Medium risk level is indicated by the MRI.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.